Antibiotic resistance in Campylobacter is on the rise, according to a new study appearing in the July 7 edition of Emerging Infectious Disease. Researchers from the National Institute of Cholera and Enteric Diseases, Kolkata, India, where Campylobacter rates remain steady throughout the year, tested 142 samples and found that all of them were resistant to trimethoprim–sulfamethoxazole, (Septra, Bactrim) and 97 percent were resistant to quinolone (nalidixic acid) and fluoroquinolones (norfloxacin, ciprofloxacin, and ofloxacin). and erythromycin, azithromycin, gentamicin, furazolidone, and chloramphenicol. Multi-drug resistance was also high.
KSWFoodWorld
FoodWorld 